Cargando…
Newborn screening for neurodevelopmental diseases: Are we there yet?
In the US, newborn screening (NBS) is a unique health program that supports health equity and screens virtually every baby after birth, and has brought timely treatments to babies since the 1960's. With the decreasing cost of sequencing and the improving methods to interpret genetic data, there...
Autores principales: | Chung, Wendy K., Berg, Jonathan S., Botkin, Jeffrey R., Brenner, Steven E., Brosco, Jeffrey P., Brothers, Kyle B., Currier, Robert J., Gaviglio, Amy, Kowtoniuk, Walter E., Olson, Colleen, Lloyd‐Puryear, Michele, Saarinen, Annamarie, Sahin, Mustafa, Shen, Yufeng, Sherr, Elliott H., Watson, Michael S., Hu, Zhanzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796120/ https://www.ncbi.nlm.nih.gov/pubmed/35838066 http://dx.doi.org/10.1002/ajmg.c.31988 |
Ejemplares similares
-
Considerations for Newborn Screening for Critical Congenital Heart Disease in Low- and Middle-Income Countries
por: Zheleva, Bistra, et al.
Publicado: (2020) -
The Progress and Future of US Newborn Screening
por: Watson, Michael S., et al.
Publicado: (2022) -
Secondary research uses of residual newborn screening dried bloodspots: a scoping review
por: Rothwell, Erin, et al.
Publicado: (2018) -
Gut Microbiome and Neurodevelopmental Disorders: A Link Yet to Be Disclosed
por: Iliodromiti, Zoi, et al.
Publicado: (2023) -
A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy
por: Al-Zaidy, Samiah A., et al.
Publicado: (2017)